Jim Simons Replimune Group, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 153,089 shares of REPL stock, worth $714,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,089

Previous 156,236 2.01%

Holding current value

$714,925

Previous $1.52 Million 6.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$6.92 - $10.38 $21,777 - $32,665	-3,147 Reduced 2.01%	153,089 $1.42 Million
Q1 2025 May 14, 2025	SELL	$9.75 - $14.31 $6,825 - $10,017	-700 Reduced 0.45%	156,236 $1.52 Million
Q4 2024 Feb 13, 2025	BUY	$10.54 - $14.93 $518,567 - $734,556	49,200 Added 45.67%	156,936 $1.9 Million
Q3 2024 Nov 13, 2024	SELL	$8.09 - $11.23 $302,703 - $420,192	-37,417 Reduced 25.78%	107,736 $1.18 Million
Q2 2024 Aug 09, 2024	SELL	$5.01 - $9.46 $79,659 - $150,414	-15,900 Reduced 9.87%	145,153 $1.31 Million
Q1 2024 May 13, 2024	BUY	$6.87 - $9.31 $873,864 - $1.18 Million	127,200 Added 375.74%	161,053 $1.32 Million
Q4 2023 Feb 13, 2024	SELL	$6.75 - $16.18 $356,717 - $855,064	-52,847 Reduced 60.95%	33,853 $285,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $1.46 Million - $2.03 Million	-91,400 Reduced 51.32%	86,700 $1.48 Million
Q2 2023 Aug 11, 2023	SELL	$15.65 - $24.1 $2.14 Million - $3.3 Million	-136,953 Reduced 43.47%	178,100 $4.14 Million
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $2.16 Million - $3.6 Million	123,700 Added 64.64%	315,053 $5.56 Million
Q4 2022 Feb 13, 2023	BUY	$17.09 - $27.91 $877,622 - $1.43 Million	51,353 Added 36.68%	191,353 $5.21 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $420,466 - $570,055	-26,953 Reduced 16.14%	140,000 $2.42 Million
Q2 2022 Aug 12, 2022	SELL	$13.32 - $19.98 $587,412 - $881,118	-44,100 Reduced 20.9%	166,953 $2.92 Million
Q1 2022 May 13, 2022	BUY	$15.24 - $29.75 $2.51 Million - $4.89 Million	164,400 Added 352.39%	211,053 $3.58 Million
Q4 2021 Feb 11, 2022	BUY	$25.43 - $34.25 $1.19 Million - $1.6 Million	46,653 New	46,653 $1.26 Million
Q1 2021 May 13, 2021	SELL	$30.22 - $45.57 $694,304 - $1.05 Million	-22,975 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$23.5 - $52.65 $539,912 - $1.21 Million	22,975 New	22,975 $876,000
Q3 2020 Nov 13, 2020	SELL	$18.85 - $27.0 $182,845 - $261,900	-9,700 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$9.76 - $25.95 $78,080 - $207,600	-8,000 Reduced 45.2%	9,700 $241,000
Q1 2020 May 14, 2020	SELL	$8.9 - $19.08 $211,820 - $454,103	-23,800 Reduced 57.35%	17,700 $176,000
Q4 2019 Feb 13, 2020	BUY	$11.61 - $17.21 $481,815 - $714,215	41,500 New	41,500 $596,000

Others Institutions Holding REPL

# of Institutions

196

Shares Held

77.6M

Call Options Held

2.06M

Put Options Held

2.86M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $230M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account